Bryan Anthony Chan, Solange Peters, Luis Leon, Tadaaki Yamada, Neeharika Srivastava Makani, Wen-Tsung Huang, Dionisios Spyratos, Jaromir Roubec, Niels Reinmuth, Adrian G. Sacher, Alexander I. Spira, Nimit Singhal, Shinji Takeuchi, Yonina R. Murciano-Goroff, Yanhong Zhou, Aaron Alan Fink, Alyson Merced, Melinda D. Willard, Carla M. Visseren Grul, Melissa Lynne Johnson. "First-line (1L) olomorasib + pembrolizumab in patients with
                    <i>KRAS</i>
                    G12C–mutant advanced NSCLC, and PD-L1 expression 0-49%, from the dose optimization cohorts of LOXO-RAS-20001 and SUNRAY-01.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8628